Family Capital Trust Co cut its position in shares of Colgate-Palmolive Co. (NYSE:CL) by 1.1% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 62,395 shares of the company’s stock after selling 715 shares during the period. Colgate-Palmolive makes up about 2.6% of Family Capital Trust Co’s portfolio, making the stock its 10th largest position. Family Capital Trust Co’s holdings in Colgate-Palmolive were worth $4,625,000 as of its most recent SEC filing.
A number of other hedge funds have also added to or reduced their stakes in CL. Vanguard Group Inc. increased its stake in Colgate-Palmolive by 1.8% in the second quarter. Vanguard Group Inc. now owns 60,839,484 shares of the company’s stock worth $4,453,451,000 after buying an additional 1,103,235 shares during the last quarter. FMR LLC increased its stake in Colgate-Palmolive by 0.8% in the second quarter. FMR LLC now owns 45,302,586 shares of the company’s stock worth $3,316,149,000 after buying an additional 373,487 shares during the last quarter. BlackRock Fund Advisors increased its stake in Colgate-Palmolive by 2.1% in the second quarter. BlackRock Fund Advisors now owns 12,570,285 shares of the company’s stock worth $920,145,000 after buying an additional 256,189 shares during the last quarter. Legal & General Group Plc increased its stake in Colgate-Palmolive by 6.1% in the second quarter. Legal & General Group Plc now owns 4,194,181 shares of the company’s stock worth $306,955,000 after buying an additional 240,916 shares during the last quarter. Finally, TIAA CREF Investment Management LLC increased its stake in Colgate-Palmolive by 4.8% in the second quarter. TIAA CREF Investment Management LLC now owns 3,059,508 shares of the company’s stock worth $223,956,000 after buying an additional 138,905 shares during the last quarter. Institutional investors own 73.12% of the company’s stock.
Shares of Colgate-Palmolive Co. (NYSE:CL) traded up 0.82% during trading on Friday, reaching $66.53. 1,302,337 shares of the company’s stock traded hands. The stock has a 50-day moving average of $69.86 and a 200-day moving average of $72.23. Colgate-Palmolive Co. has a 1-year low of $61.40 and a 1-year high of $75.38. The company has a market capitalization of $59.13 billion, a price-to-earnings ratio of 43.51 and a beta of 0.73.
Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Thursday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.73. Colgate-Palmolive had a net margin of 8.96% and a return on equity of 6,924.14%. The company had revenue of $3.87 billion for the quarter, compared to the consensus estimate of $3.94 billion. During the same quarter in the prior year, the firm earned $0.80 earnings per share. The company’s revenue for the quarter was down 3.3% compared to the same quarter last year. On average, equities analysts predict that Colgate-Palmolive Co. will post $2.82 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, November 15th. Shareholders of record on Monday, October 24th were issued a $0.39 dividend. This represents a $1.56 annualized dividend and a dividend yield of 2.34%. The ex-dividend date was Thursday, October 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 101.96%.
A number of analysts have recently issued reports on CL shares. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price target for the company in a report on Monday, October 3rd. Exane BNP Paribas downgraded shares of Colgate-Palmolive from an “outperform” rating to a “neutral” rating in a report on Friday, July 29th. JPMorgan Chase & Co. restated a “hold” rating and set a $75.00 price target on shares of Colgate-Palmolive in a report on Friday, July 29th. B. Riley restated a “neutral” rating and set a $78.00 price target (up previously from $71.00) on shares of Colgate-Palmolive in a report on Friday, October 28th. Finally, Wells Fargo & Co. restated a “market perform” rating on shares of Colgate-Palmolive in a report on Tuesday, November 15th. Twelve analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $76.04.
In other Colgate-Palmolive news, insider Patricia Verduin sold 3,834 shares of the company’s stock in a transaction dated Monday, October 17th. The shares were sold at an average price of $72.39, for a total value of $277,543.26. Following the sale, the insider now owns 55,013 shares of the company’s stock, valued at $3,982,391.07. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.05% of the stock is currently owned by company insiders.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The Company’s segments include Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through over five geographic segments, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.